World's Best Scientists 2026 revealed!
Fernando A. Bozza

Fernando A. Bozza

D-Index & Metrics

Medicine

D-Index
84
Citations
24903
World Ranking
15143
National Ranking
42

Fernando A. Bozza publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fernando A. Bozza sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 390 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fernando A. Bozza D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fernando A. Bozza sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fernando A. Bozza is affiliated with the Oswaldo Cruz Foundation in Brazil. Their research primarily focuses on medical and clinical studies, with a significant emphasis on infectious diseases and critical care medicine. Bozza has contributed extensively to fields such as infectious diseases, neurology, epidemiology, public health, environmental and occupational health, and critical care and intensive care medicine.

Their main topics of research include COVID-19 clinical research studies, long-term effects of COVID-19, intensive care unit cognitive disorders, sepsis diagnosis and treatment, SARS-CoV-2 and COVID-19 research, COVID-19 epidemiological studies, and mosquito-borne diseases and control. This range highlights a particular focus on infectious diseases and critical care scenarios linked to the COVID-19 pandemic.

Bozza has been published frequently in several scientific venues known for disseminating research in the medical and critical care fields. Notable frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Critical Care Science
  • Journal of Critical Care
  • Intensive Care Medicine

Their recent papers illustrate the scope and depth of their scholarly contributions. These include:

  • A minimal common outcome measure set for COVID-19 clinical research (2020) - The Lancet Infectious Diseases
  • Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 (2020) - Blood
  • Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data (2021) - The Lancet Respiratory Medicine
  • Septic-Associated Encephalopathy: a Comprehensive Review (2020) - Neurotherapeutics
  • Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators (2020) - PLoS Pathogens

Bozza frequently collaborates with other researchers, which is evident from recurring co-authorship. Their most common collaborators include:

  • Leonardo dos Santos Lourenço Bastos
  • Patrícia T. Bozza
  • Pedro Kurtz
  • Sílvia Hamacher
  • Jorge I. Salluh

Best Publications

  • A minimal common outcome measure set for COVID-19 clinical research

    John C. Marshall;Srinivas Murthy;Janet Diaz;Neil Adhikari

  • Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis

    Fernando A. Bozza;Fernando A. Bozza;Jorge I F Salluh;André M Japiassú;André M Japiassú;Marcio Soares

  • Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.

    Eugenio D. Hottz;Eugenio D. Hottz;Isaclaudia G. Azevedo-Quintanilha;Lohanna Palhinha;Lívia Teixeira

  • A central role for free heme in the pathogenesis of severe sepsis.

    Rasmus Larsen;Raffaella Gozzelino;Viktória Jeney;László Tokaji

  • Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity

    Fernando A Bozza;Oswaldo G Cruz;Sonia M O Zagne;Elzinandes L Azeredo

  • Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.

    Otavio T Ranzani;Leonardo S L Bastos;João Gabriel M Gelli;Janaina F Marchesi

  • Zika virus evolution and spread in the Americas

    Hayden C. Metsky;Hayden C. Metsky;Christian B. Matranga;Shirlee Wohl;Shirlee Wohl;Stephen F. Schaffner;Stephen F. Schaffner

  • Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza

    Nyall R. London;Weiquan Zhu;Fernando A. Bozza;Matthew C. P. Smith

  • The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study

    Flavia R Machado;Alexandre Biasi Cavalcanti;Fernando Augusto Bozza;Elaine M Ferreira

  • A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.

    Giorgio Zavagno;Gian Luca De Salvo;Giuliano Scalco;Fernando Bozza

  • Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study.

    Márcio Soares;Pedro Caruso;Eliézer Silva;José M. M. Teles

  • Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation

    Eugenio D. Hottz;Juliana F. Lopes;Carla Freitas;Rogério Valls-de-Souza

  • Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.

    Suelen Silva Gomes Dias;Vinicius Cardoso Soares;Vinicius Cardoso Soares;André C. Ferreira;Carolina Q. Sacramento

  • Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials.

    Sachin Yende;Shamly Austin;Andrew Rhodes;Simon Finfer

  • SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

    André C. Ferreira;Vinicius Cardoso Soares;Vinicius Cardoso Soares;Isaclaudia G. de Azevedo-Quintanilha;Suelen da Silva Gomes Dias

  • Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC‐SIGN and caspases

    E. D. Hottz;M. F. Oliveira;P. C. G. Nunes;R. M. R. Nogueira

  • MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSIS

    Fernando A Bozza;Rachel N Gomes;André M Japiassú;Marcio Soares

  • Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

    Jayant S Vaidya;Max Bulsara;Michael Baum;Frederik Wenz

  • Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis

    Cássia Righy;Regis Goulart Rosa;Rodrigo Teixeira Amancio da Silva;Renata Kochhann

  • The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

    Carolina Q. Sacramento;Gabrielle R. de Melo;Caroline S. de Freitas;Natasha Rocha

Frequent Co-Authors

Patrícia T. Bozza
Patrícia T. Bozza Oswaldo Cruz Foundation
Hugo C. Castro-Faria-Neto
Hugo C. Castro-Faria-Neto Oswaldo Cruz Foundation
Guy A. Zimmerman
Guy A. Zimmerman University of Utah
Derek C. Angus
Derek C. Angus University of Pittsburgh
Felipe Dal-Pizzol
Felipe Dal-Pizzol Universidade do Extremo Sul Catarinense
Marcelo T. Bozza
Marcelo T. Bozza Federal University of Rio de Janeiro
Fabiano L. Thompson
Fabiano L. Thompson Federal University of Rio de Janeiro
Andrew S. Weyrich
Andrew S. Weyrich University of Utah
Lee Gehrke
Lee Gehrke Harvard University
Fabrice Chrétien
Fabrice Chrétien Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a variety of related fields, many of which can be pursued through flexible online study. Those interested in healthcare leadership should consider online healthcare administration programs. These degrees help build management and organizational skills vital for today’s medical environments.

When assessing graduate options, cost is a significant concern for many students. The cost of mha degree has become more accessible thanks to competitively priced online options. Similarly, nurses looking to advance their practice may explore the cheapest bsn to dnp programs for affordable pathways to earning a Doctor of Nursing Practice.

Pharmacy is another promising healthcare career. For those seeking flexible study, online pharm d programs offer a way to earn a doctorate with less disruption to your current work or life commitments.

Exploring these options can help you find the right balance between education, flexibility, and cost as you shape your healthcare career path.

Best Scientists Citing Fernando A. Bozza

Trending Scientists

Recently Published Articles